ABSTRACT Enoyl-acyl carrier protein reductases (ENR), such as FabI, FabL, FabK, and FabV, catalyze the last reduction step in bacterial type II fatty acid biosynthesis. Previously, we reported metagenome-derived ENR homologs resistant to triclosan (TCL) and highly similar to 7-␣ hydroxysteroid dehydrogenase (7-AHSDH). These homologs are commonly found in Epsilonproteobacteria, a class that contains several human-pathogenic bacteria, including the genera Helicobacter and Campylobacter. Here we report the biochemical and predicted structural basis of TCL resistance in a novel 7-AHSDH-like ENR. The purified protein exhibited NADPH-dependent ENR activity but no 7-AHSDH activity, despite its high homology with 7-AHSDH (69% to 96%). Because this ENR was similar to FabL (41%), we propose that this metagenome-derived ENR be referred to as FabL2. Homology modeling, molecular docking, and molecular dynamic simulation analyses revealed the presence of an extrapolated six-amino-acid loop specific to FabL2 ENR, which prevented the entry of TCL into the active site of FabL2 and was likely responsible for TCL resistance. Elimination of this extrapolated loop via site-directed mutagenesis resulted in the complete loss of TCL resistance but not enzyme activity. Phylogenetic analysis suggested that FabL, FabL2, and 7-AHSDH diverged from a common short-chain dehydrogenase reductase family. This study is the first to report the role of the extrapolated loop of FabL2-type ENRs in conferring TCL resistance. Thus, the FabL2 ENR represents a new drug target specific for pathogenic Epsilonproteobacteria.
for establishing and maintaining the rate of fatty acid biosynthesis (31, 32) . Amino acid sequence analysis revealed that FabL2 shared significant homology (69% to 96%) with the 7-AHSDH homologs of Epsilonproteobacteria and relatively less similarity to FabL (41%), FabI (27%), and prototypic 7-AHSDH (34%) (20) . Moreover, FabL2 ENR shared similar structural features, such as highly conserved tyrosine and lysine residues of the active site, with prototypic FabI and FabL ENRs. Similarly, key residues of the enzyme, such as Ser146, Lys163, Thr193 and RINA-like sequences, were strictly conserved among the FabL2 ENR and prototypic 7-AHSDH (20) .
Additionally, the FabL2 protein conferred complete TCL tolerance when expressed in E. coli and complemented the ENR activity in the E. coli mutant JPP1111, carrying the fabI(Ts) mutation (20) . Phylogenetic analysis of the FabL2 protein with other prototypic ENRs and 7-AHSDH proteins and their homologs revealed that FabL2-type ENRs clustered as a separate clade (Fig. 2) , suggesting that FabL2 diverged either from closely related FabL and FabI ENRs or from 7-AHSDH during evolution. Therefore, we designated this enzyme FabL2. Consequently, distinguishing these types of ENRs based only on sequence comparison/annotation is not always ideal (20) .
NADPH-dependent ENR activity of the FabL2 protein.
A fusion protein of FabL2 was purified and confirmed to be of expected size (33.56 kDa) using SDS-PAGE (see Fig.  S2A and B in the supplemental material). The conversion of NADH/NADPH cofactors to NAD/NADP at 340 nm was monitored to assess the ENR activity. Because the purified protein exhibited maximum activity in 100 mM sodium phosphate buffer (pH 7.0) (Fig.  S2C ), all subsequent assays were performed using this buffer. No enzymatic activity was observed in 100 mM sodium citrate buffer regardless of the pH (data not shown). The purified protein catalyzed the turnover of NADPH (Michaelis constant [K m ] ϭ 27.64 M) (Fig. 3A) into NADP in the presence of crotonyl coenzyme A (crotonyl-CoA) (K m ϭ 9.627 M) as a substrate (Fig. 3B ). These K m values for the metagenomic ENR were equivalent to those reported for Chlamydia trachomatis and E. coli ENRs (4, 33) , although these values were slightly lower than those reported by Ward et al. and Basso et al. (34, 35) . The purified protein did not utilize NADH as a cofactor, thus exhibiting ENR activity only with NADPH.
Among other prototypic ENRs, FabL from Bacillus subtilis showed high similarity to FabL2 ENR (41%), which uses NADPH as a cofactor (4), whereas FabV using NADPH as a cofactor (1) did not show any similarity to FabL2. The k cat values for FabL2 with NADPH (1.09 M/min) and crotonyl-ACP (0.18283 M/min) (Table S1 ) were within the range reported previously (36) but were lower than those for the ENR from C. trachomatis (33) . These variations might be due to the use of different substrates. Overall, biochemical analyses confirmed that FabL2 enzyme possesses NADPH-dependent ENR activity. However, despite its high similarity to 7-AHSDH from Epsilonproteobacteria, FabL2 did not exhibit 7-AHSDH activity when tested with cholic acid substrate and NADH and NADPH cofactors (data not shown). These data suggest that the enzyme FabL2 from soil metagenome is a bona fide ENR similar to FabL.
Predicted structure of FabL2. Sequence analysis of metagenomic TCL-resistant FabL2 showed 41.0% sequence similarity with FabL from B. subtilis. Sequence alignment revealed Gly102, Tyr160, Lys167, and Phe204 as the catalytic residues of FabL2 ( Fig. 4A ) and an extrapolated loop to be tested for TCL resistance (Fig. 4B ) and ENR function (Fig. 4C) . Therefore, the structure of FabL from B. subtilis (PDB code 3OID; chain A) was considered the template for homology modeling of FabL2. Among 10 predicted models, the best model of FabL2 was selected based on the lowest molecular probability density function (MOLPDF) score of 1,414.23 and discrete optimized protein energy (DOPE) score of Ϫ26,020.47. The representative structure of FabL2 was extracted after molecular dynamic (MD) simulation refinement. The stereochemical quality of the refined FabL2 structure revealed that 88.6% of the residues occupied the most favored region of the Ramachandran plot (37) (Fig. S3A) . These results suggest that phi and psi backbone dihedral angles in the modeled structure are reasonably accurate. Analysis of FabL2 with ProSA-web (38) revealed a Z-score of Ϫ7.31, which was within the range of Z-scores of experimentally determined structures (Fig. S3B) .
The MD-refined structure of FabL2 has an architecture similar to that reported for FabL proteins (39) . Briefly, the overall structure of FabL2 comprises a central 7-stranded parallel ␤-sheet (␤1 to ␤7) sandwich-like structure flanked on both sides by three ␣-helices, forming an NADPH-binding Rossman-like fold (40) (Fig. 5A ). Our modeled FabL2 structure also exhibited the same folding pattern in the substrate-binding region (␣8 and ␣9) located near the carboxyl end of ␤6 and ␤7 as previously described for different ENRs and other members of the SDR family (4, 41, 42) . Despite the high similarity of FabL2 with FabL from B. subtilis, FabL2 contained an extrapolated region extending between Tyr96 and Val101 ( Fig. 4A and 5A and B). The structural superimposition of FabL2 and FabL affirmed that the extrapolated six amino acid residues formed a loop (Fig. 5A, orange) . The role of this loop in substrate specificity and TCL resistance of FabL2 was subsequently validated.
Interaction of TCL with FabL2. The best docking pose of TCL with FabL2 revealed a Genetic Optimization of Ligand Docking (GOLD) fitness score of 53.00. Despite the high docking score, TCL was flipped away (ϳ5.7 Å) from the catalytic site of FabL2 and was bound at the rim region of the tunnel leading to the substrate binding site (Fig. 5B) . Furthermore, despite the phenol moiety, the phenoxy group of TCL was oriented toward the catalytic pocket of FabL2. Molecular interactions between FabL2 and TCL implied that the Arg98 residue of the extrapolated loop formed two H bonds with the backbone oxygen and phenolic oxygen of TCL (Fig. 5C ). Moreover, other nonpolar interactions confirmed the binding of TCL at the rim region of the tunnel leading to the catalytic site of FabL2 (Fig. 5C ). Our rational approach concluded that TCL could not reach the catalytic site of FabL2 due to H bonding with Arg98 and other nonpolar interactions ( Fig. 5A and B ). This flexible loop may determine the shape and size of the tunnel. We further speculate that the extrapolated loop is highly flexible and plays a key role in TCL resistance of FabL2.
Based on our results, we hypothesized that removing this extrapolated flexible loop (Tyr96 to Val101) from FabL2 renders it sensitive to TCL. To test this hypothesis, we created mutant FabL2 (mFabL2) lacking the extrapolated loop and predicted its structure as previously described for FabL2 (Fig. 4B ). The best model had the lowest PDF and DOPE scores, 1,353.46 and Ϫ24,680.74, respectively. PROCHECK analysis of mFabL2 revealed that 92.6% of amino acid residues occupied the most favored region of the Ramachandran plot (Fig. S3C) . The Z-score of mFabL2 model was Ϫ6.74, which followed the Z-score pattern of wild-type FabL2 (Fig. S3D ). FabL2 and mFabL2 showed a similar overall topologies and model qualities, except for the tunnel leading to catalytic cavity (Fig. 5D ). Based on these data, we speculate that the native function of mFabL2 was unaffected by the deletion of the flexible loop.
Although the docking score of mFabL2 was the same as that of wild-type FabL2 (53.00), TCL occupied the catalytic active site of mFabL2. The binding of TCL with mFabL2 was similar to that observed with other ENR family members with respect to the orientation of the phenol moiety toward the substrate binding site (Fig. 5E) . Moreover, the H bonding between TCL and Tyr154 of mFabL2 stabilized its orientation in the active site of mFabL2 (Fig. 5F) . Further, the H bonding between amino acid residues of mFabL2 and NADPH generated a stable enzyme complex of mFabL2 (Fig. 5G) . This binding pattern of TCL is conserved across all ENR family members (28, 39, 43, 44) . MD simulation of the mFabL2-TCL complex. Detailed analysis of the binding mode of TCL with the active site of mFabL2 was conducted via 20-ns MD simulation. The root mean square deviation (RMSD) of the C␣ atoms (Fig. 5H) , the simulation of the mFabL2-TCL complex (Fig. 5I) , and analysis of molecular interactions ( Fig. 5J ; see also Fig. S4A and B) indicated that the system remained stable during the entire simulation period. This mechanism of targeting the catalytic Tyr by TCL is well documented among other ENR family members (28, 39, 44) . Our analysis also revealed an additional interaction between NADPH and TCL via H bonding (Fig. S4A and B) , which may strengthen the binding of TCL with mFabL2. Moreover, other molecular interactions, including -, alkyl-alkyl, -alkyl, and van der Waals interactions, were observed between the catalytic site residues of mFabL2 and TCL ( Fig. 5G ; see also Table S2 ). Taken together, these data validated our hypothesis and revealed that the deletion of the extrapolated residues did not disturb the native folding of mFabL2 and restore its sensitivity to TCL. Experimental validation confirmed the native function of mFabL2 as well as its inhibition by TCL.
The extrapolated loop of FabL2 is involved in TCL resistance. Bioinformatics analysis revealed that FabL2 has an extra six-residue loop (Tyr96 to Val101), which was specific to and supposed to be involved in TCL tolerance. These six residues extend the loop dramatically, which pushes Gly102 (conserved catalytic residue) away, creating a new topology of the TCL binding site of FabL2. We speculate that Arg98, which is sequestered between Gly102 and TCL, interferes with their binding. Moreover, docking analysis of mFabL2 revealed that TCL is able to access the active site of mFabL2. Therefore, we conclude that the loop from Tyr96 to Val101 is responsible for the observed TCL tolerance of FabL2; its removal may result in the loss or reduction of TCL resistance. As expected, deletion of the loop from Tyr96 to Val101 via site-directed mutagenesis resulted in the loss of TCL resistance in mFabL2 (MIC, 2.5 g/ml), whereas wild-type FabL2 was capable of conferring resistance to TCL even at concentrations as high as 600 g/ml (Fig. S5A and B) . Moreover, complementation analysis revealed that mFabL2 retained its ENR activity (Fig. 4C ). This result indicates that the loop from Tyr96 to Val101 is involved in TCL tolerance but not in ENR activity. The strict amino acid conservation of this extrapolated loop (Fig. S6A) suggests that the loop was recently introduced into FabL2 of Epsilonproteobacteria.
The extrapolated loop is highly unique and is present only in FabL2-type ENR and its homologs in Epsilonproteobacteria; it is absent in the closely related prototypic FabL-type ENRs and prototypic 7-AHSDH homologs (Fig. S6A and B and Table S3 ). It is unclear how and why these enzymes have evolved to contain this extrapolated loop. However, this extrapolated loop (Tyr96 to Gly102) in FabL2 is involved in the topology of tunnel leading to the enzyme active site. The residues of the target loop are not considered catalytic moieties of ENR, since removal of the loop did not affect ENR activity. Although we have not tested specific point mutation of the extrapolated loop, we speculate that specific point mutation of the loop would not alter the overall structure of the loop. Our rational approach suggested that extrapolated loop is highly flexible and fluctuates back and forth to open and close the opening of the tunnel leading to the active site of FabL2 (Fig. 5A) . However, this prediction still awaits further biochemical investigation.
Our analysis of docking of TCL into the active site of FabL2 suggested that TCL is flipped away from docking site by ϳ5.7 Å, and hence, TCL could not reach the catalytic site. If we delete this loop, the main entrance of the tunnel will remain open and TCL would be able to reach the active site of FabL2. In fact, deletion of extrapolated loop could successfully abolish TCL resistance in mFabL2. Finally, we perceived that extrapolated loop of FabL2 serves as a checkpoint to selectively allow the substrate(s) to reach the active site, which needs to be further verified by structural characterization. Taken together, the findings of this study showed that minor changes in the structure of bacterial proteins due to small-scale structural variations in the coding sequence can render the bacteria resistant to antibiotics.
Conclusions. We conclude that FabL2 ENR confers complete TCL tolerance via a unique extrapolated loop in its protein structure. This study is the first to show TCL tolerance conferred by residues other than those directly interacting with the substrate or cofactor. Furthermore, the presence of TCL-resistant FabL2 ENR homologs among the human-pathogenic bacteria of the Epsilonproteobacteria class indicates that these bacteria may be unaffected by TCL treatment. Additionally, although the amino acid sequence of FabL2 was highly similar to that of 7-AHSDH, the lack of 7-AHSDH activity in FabL2 indicates that sequence alignments alone are not sufficient for determining protein function.
MATERIALS AND METHODS
Bacterial strains, plasmids, culture conditions, and general DNA manipulation. E. coli strains DH5␣, EPI300, and BL21(DE3) were grown at 37°C in Luria-Bertani (LB) broth or on LB agar media containing appropriate antibiotics: TCL (1 to 600 g/ml; Sigma-Aldrich Co., St. Louis, MO), chloramphenicol (50 g/ml), ampicillin (100 g/ml), or kanamycin (50 g/ml). Recombinant DNA manipulation was performed as previously described (45) . Oligonucleotide synthesis and DNA sequencing were conducted at the DNA sequencing facility of MacroGen (Seoul, Republic of Korea). Nucleotide and amino acid sequences were compared using the online version of BLAST and ORF finder, publicly available at the National Center for Biotechnology Information (NCBI) portal (http://blast.ncbi.nlm.nih.gov). Multiple sequence alignments were performed using BioEdit v7.2.5 and GeneDoc v2.7 software.
Phylogenetic analysis. Phylogenetic analysis was performed as previously described (20) for metagenomic FabL2 ENR using amino acid sequences of FabL2 and its homologs, prototypic FabL, FabI, FabV, FabK ENRs, and prototypic 7-AHSDH from Comamonas testosteroni and its homologs retrieved from the UniRef50 database (updated on 19 September 2017). Top 10 entries were selected from each homology search. All identified sequences compiled together with the closely related prototypic ENRs and metagenomic FabL2, and redundant sequences were removed using the online Decrease Redundancy program (46) . Sequence alignment and phylogenetic tree construction were performed with MEGA 6 (47) using the MUSCLE algorithm (48) . To analyze the alignment output in MEGA 6, the maximum likelihood method was used in combination with the nearest-neighbor-interchange strategy, resulting in the deletion of gaps present in less than 50% of the sequences and generating 500 bootstrapped replicates resampling data sets to evaluate the confidence.
Expression and purification of FabL2 ENR. A gene encoding FabL2 ENR was PCR amplified from pBF1-4 (20) using gene-specific forward primer (5=-ATTCAAGGATCCTAGAGACATGACAAATATGAAAGGC AA-3=) and reverse primer (5=-TTATCATCTTTTAACATATAATAGATGGTCGACTTTCAA-3=) containing BamHI and SalI restriction sites (underlined), respectively. The amplified PCR product was digested with BamHI and SalI restriction endonucleases and cloned into pET-30b(ϩ) expression vector to generate the recombinant vector pEBF1-4.
To express the FabL2 protein, pEBF1-4 was transformed into E. coli BL21(DE3) cells, and recombinant cells were selected on LB agar medium containing kanamycin. E. coli cells carrying pEBF1-4 were grown in 200 ml of LB supplemented with kanamycin at 37°C until reaching an optical density of 0.5 at 600 nm (OD 600 ). To induce protein expression, isopropyl ␤-D-1-thiogalactopyranoside (IPTG) (1 mM) was added to the bacterial culture during the late exponential phase. For protein purification, E. coli cells were harvested, resuspended in 5 ml of binding buffer (20 mM Tris-Cl, 0.5 M NaCl, 40 mM imidazole [pH 8.0]), and subjected to sonication (sonic dismembrator model 500; Fisher Scientific) for 2 min (pulse ON, 5 s; pulse OFF, 10 s). This mixture was then centrifuged at 3,500 ϫ g for 6 min at 25°C. The supernatant was collected and recentrifuged at 17,000 ϫ g for 10 min at 25°C and filtered using a 0.45-m membrane filter. The fusion protein was purified using AKTA prime liquid chromatography system (GE Healthcare, Buckinghamshire, UK) with a His Trap HP affinity column (1-ml bed volume; GE Healthcare). The identity of the purified fusion protein was confirmed by denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). (52) . Briefly, the system was solvated in an octahedral box of transferable intermolecular potential three position (TIP3P) water model. Counterions (Na ϩ ) were added to neutralize the system. The steepest descent minimization with a maximum tolerance of 10 kJ/mol/nm was employed to avoid any unfavorable interactions. The system was equilibrated in two phases. In the first phase, NVT (number of particles at constant volume and temperature) equilibration was conducted for 100 ps at 300 K. The temperature was maintained with a V-rescale thermostat. In the second phase, heavy atoms were restrained, and solvent molecules with counterions were allowed to move during the 100-ps simulation at 300 K and 10 5 Pa pressure using the Parrinello-Rahman barostat. The final production step was conducted for 10 ns under periodic boundary conditions with NPT (number of particles at constant pressure and temperature) ensemble and bond constraint algorithm, linear constraint solver (LINCS). The representative structure of FabL2 was extracted from the last 6-ns trajectory using the clustering method. The stereochemical quality of the MD-refined model of FabL2 was verified using PROCHECK implemented in SAVES web server (http://services.mbi.ucla.edu/ PROCHECK/). The MD-refined model of FabL2 was also validated by ProSA-web (https://prosa.services .came.sbg.ac.at/prosa.php) for its accuracy of potential errors. The Z-score of ProSA measures the deviation of the total energy of the structure with respect to an energy distribution derived from random conformations.
Molecular docking simulation of TCL into FabL2. Molecular docking is a computational technique used to predict the binding affinity and orientation of a ligand in the binding site of a protein. The two-dimensional (2D) structure of TCL was drawn in Accelrys Draw v4.2 and converted into three-dimensional (3D) structure in Discovery Studio v4.5. The MD-refined model of FabL2 and TCL was used as input data in the Genetic Optimization of Ligand Docking (GOLD) v5.2.2 program. The binding site of FabL2 was traced from its catalytic residues using Define and Edit Binding Site tools implemented in Discovery Studio v4.5. Docking results were analyzed with the GOLD fitness score, which includes hydrogen bond (H bond) energy, van der Waals energy, and ligand torsion strains. The best docking pose was selected based on the GOLD fitness score and H bonding with catalytic residues. Accession number(s). The nucleotide sequence of pBF1 harboring the FabL2 gene has been deposited in the GenBank database under accession number KT982367. The FabL2 ENR protein sequence has been deposited in the NCBI protein database under accession number AOR51268.1.
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